Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Patented Medicine Prices Review Board (PMPRB) in Monthly Communication Reports in: April 2022

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

Results 1-2 of 2

  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Industry
    Communication date: 2022-04-14
    Posted date: 2022-04-29
    Communication number: 15270-530329 View associated registration
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health
    Communication date: 2022-04-07
    Posted date: 2022-05-16
    Communication number: 6034-531020 View associated registration
Return to Government Institutions in Monthly Communication Reports
Date Modified: